Poly[(dimethyliminio)hexamethylene(dimethyliminio)decamethylenebromide (1:2)]

Suppliers

Names

[ CAS No. ]:
28728-57-6

[ Name ]:
Poly[(dimethyliminio)hexamethylene(dimethyliminio)decamethylenebromide (1:2)]

Chemical & Physical Properties

[ Molecular Formula ]:
C20H44N2++

[ Molecular Weight ]:
312.57700

[ Exact Mass ]:
312.35000

[ LogP ]:
5.25230

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TQ2648000
CHEMICAL NAME :
Poly((dimethyliminio)hexamethylene(dimethyliminio)dec amethylene dibromide)
CAS REGISTRY NUMBER :
28728-57-6
LAST UPDATED :
198806
DATA ITEMS CITED :
2

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4013507
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4013507

Related Compounds

  • L-Norvaline-1-13C
  • Acetic-1-13C-2-bromoacid Methyl Ester
  • Phosphoric acid (18O4, 96%) 80-85% IN water-18O
  • 3-(1-Trityl-1H-imidazol-4-YL)-propylamine oxalate
  • Nalpha-Fmoc-L-tryptophan-15N2
  • 2-(Chloromethyl)-6-methoxypyridin-4-OL
  • Ethyl 2-(3-((tert-butoxycarbonylamino)methyl)oxetan-3-YL)acetate
  • Ethyl 2-(3-(benzyloxycarbonylamino)oxetan-3-YL)acetate
  • Ethyl 2-(3-(cyclopentylamino)oxetan-3-YL)acetate
  • Ethyl 2-(3-(4-hydroxycyclohexylamino)oxetan-3-YL)acetate
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.